Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOOR
676
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $15.8M | 0.03% |
260,175
+168,205
| +183% | +$11.2M |
|
677
EPR Properties
EPR
$4.64B
| $15.8M | 0.03% |
305,452
+292,720
| +2,299% | +$15.8M |
|
678
Johnson & Johnson
JNJ
$658B
| $15.7M | 0.03% |
168,593
-174,194
| -51% | -$16.9M |
|
679
FNB Corp
FNB
$6.58B
| $15.7M | 0.03% |
+1,214,951
| New | +$16.2M |
|
|
RDS.B
680
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $15.7M | 0.03% |
331,016
+225,443
| +214% | +$12.1M |
|
681
Keysight
KEYS
$52.9B
| $15.7M | 0.03% |
509,562
+156,038
| +44% | +$4.86M |
|
|
VSTO
682
DELISTED
Vista Outdoor Inc.
VSTO
| $15.6M | 0.03% |
351,676
+303,151
| +625% | +$13.8M |
|
683
PUT
Vertex Pharmaceuticals
VRTX
$139B
| $15.6M | 0.03% |
+150,000
| New | +$19.3M |
|
684
CALL
Energy Transfer Partners
ET
$72.6B
| $15.6M | 0.03% |
749,400
-927,200
| -55% | -$26.2M |
|
685
James River Group Holdings
JRVR
$190M
| $15.6M | 0.03% |
579,960
+46,760
| +9% | +$1.27M |
|
|
SVU
686
DELISTED
SUPERVALU Inc.
SVU
| $15.6M | 0.03% |
309,849
+216,081
| +230% | +$12.4M |
|
|
CHK
687
PUT
DELISTED
Chesapeake Energy Corporation
CHK
| $15.6M | 0.03% |
10,617
| – | – |
|
688
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.5B
| $15.6M | 0.03% |
+250,000
| New | +$19.7M |
|
689
Zimmer Biomet
ZBH
$19.3B
| $15.5M | 0.03% |
169,982
-243,320
| -59% | -$24.4M |
|
|
FNHC
690
DELISTED
FedNat Holding Company Common Stock
FNHC
| $15.5M | 0.03% |
644,486
+119,969
| +23% | +$2.81M |
|
691
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $15.5M | 0.03% |
192,389
+35,354
| +23% | +$2.83M |
|
|
ENV
692
DELISTED
ENVESTNET, INC.
ENV
| $15.4M | 0.03% |
514,599
+406,006
| +374% | +$14.9M |
|
693
Stagwell
STGW
$2.17B
| $15.4M | 0.03% |
+836,755
| New | +$15.7M |
|
|
NXTM
694
DELISTED
NxStage Medical Inc.
NXTM
| $15.4M | 0.03% |
974,239
+328,478
| +51% | +$5.27M |
|
695
Central Pacific Financial
CPF
$972M
| $15.4M | 0.03% |
732,075
+411,985
| +129% | +$9.08M |
|
|
ECHO
696
EchoStar
ECHO
$24.8B
| $15.3M | 0.03% |
439,108
+142,176
| +48% | +$5.24M |
|
697
Insperity
NSP
$1.99B
| $15.3M | 0.03% |
695,160
+312,856
| +82% | +$7.44M |
|
|
JOY
698
DELISTED
Joy Global Inc
JOY
| $15.2M | 0.03% |
1,020,608
+380,787
| +60% | +$9.24M |
|
|
MWE
699
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $15.2M | 0.03% |
+354,016
| New | +$20.2M |
|
700
W.W. Grainger
GWW
$62.3B
| $15.2M | 0.03% |
70,566
+33,933
| +93% | +$7.62M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.